Cancers, Free Full-Text

Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.

ACS: 31,500 diagnosed with HPV cancers annually, most preventable with vaccine

Destination Healthy Skin Toolkit - The Skin Cancer Foundation

Institutional Repository LinkOut: A New Full Text Access Feature in PubMed. NLM Technical Bulletin. 2017 Mar–Apr

An Introduction to Human Cancers

What is secondary lung cancer?

OncLive - Clinical Oncology News, Cancer Expert Insights

from Flow Cytometry to Cytomics, Page 2

Cancer free hi-res stock photography and images - Alamy

Prostate Cancer: Symptoms, Causes & Treatment

Preventing cancer

Cancer - Wiley Online Library

I Am Cancer Free! - Cancer Free Gift - Tapestry

Blood Test for Cancer Screening

Remission, cancer-free, no evidence of disease: What's the difference?

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization